Effectiveness of intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration: visual And Anatomical Results - A Real-Life Retrospective Study
Journal of Ophthalmology and Eye Disorders · 04.02.2025
DOI: 10.52338/joed.2025.4374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ophthalmology and Eye Disorders, online erschienen am 04.02.2025. Verfasst von Maria Isabel Sampaio Tom Back und 6 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the effectiveness intravitreal bevacizumab in the treatment of neovascular macular degeneration (n-ARMD) in a real-life scenario.
Method
Retrospective, longitudinal study that evaluated the medical records of 101 eyes (89 patients) with n-ARMD who received intravitreal bevacizumab, in a Pro Re Nata (PRN) treatment regimen, between July 2021 and March 2024.
Results
After one year of follow-up, 41 eyes (41.4%) showed improvement in VA, 32 (32.3%) showed a decline in VA, and 26 (26.3%) maintained stable VA. There was a significant reduction in median central macular thickness, with a decrease from 317 µm at baseline to 271 µm (p-value < 0.001; ∆ = 46 µm). Of all variables evaluated, the number of visits was the only modulator significantly correlated with VA improvement (p = 0.008).
Conclusion
In our study, the majority of patients treated with Bevacizumab improved or maintained their CCVA status. Therefore, bevacizumab in a PRN regimen was effective in the treatment of n-ARMD, supporting its use in a high-throughput public service. Our study also reinforced the clinical application of OCT-based anatomical results to individualize and optimize therapeutic strategies and protocols for patients Financial Disclosure(s): The author(s) have no commercial interest in any of the discussed subjects.
Zitieren
APA
Back, M. I. S. T., Gandra, A. L. S., Back, B. F. D. C. T., Abreu, G., Soares, A. N., Pereira, F. B., & Souza, A. H. D. (2025). Effectiveness of intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration: visual And Anatomical Results - A Real-Life Retrospective Study. Journal of Ophthalmology and Eye Disorders. https://doi.org/10.52338/joed.2025.4374
Vancouver
Back MIST, Gandra ALS, Back BFDCT, Abreu G, Soares AN, Pereira FB, et al. Effectiveness of intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration: visual And Anatomical Results - A Real-Life Retrospective Study. Journal of Ophthalmology and Eye Disorders. 2025. doi:10.52338/joed.2025.4374
BibTeX
@article{Back2025,
author = {Back, Maria Isabel Sampaio Tom and Gandra, Ana Luisa Souto and Back, Bernardo Franco de Carvalho Tom and Abreu, Gabriel and Soares, Aleida Nazareth and Pereira, Frederico Braga and Souza, Alessandra Hubner de},
title = {Effectiveness of intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration: visual And Anatomical Results - A Real-Life Retrospective Study},
journal = {Journal of Ophthalmology and Eye Disorders},
year = {2025},
doi = {10.52338/joed.2025.4374}
}
EUVIMED